Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 3:45 pm Sale | 2024-12-31 | 13G | ANAPTYSBIO INC ANAB | Fairmount Funds Management LLC | 0 0.000% | -2,507,226 (Position Closed) | Filing History |
| 2025-02-14 11:27 am Sale | 2025-01-31 | 13G | ANAPTYSBIO INC ANAB | Frazier Life Sciences Public Fund L.P. | 694,862 1.500% | -1,788,080 (-72.01%) | Filing History |
| 2025-02-14 11:25 am Sale | 2024-12-31 | 13G | ANAPTYSBIO INC ANAB | Frazier Life Sciences Public Fund L.P. | 2,482,942 5.400% | -392,844 (-13.66%) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | ANAPTYSBIO INC ANAB | BlackRock Inc. BLK | 3,822,702 8.400% | 1,122,968 (+41.60%) | Filing History |
| 2024-12-18 4:30 pm Purchase | 2024-12-11 | 13G | ANAPTYSBIO INC ANAB | Fairmount Funds Management LLC | 2,507,226 5.500% | 2,507,226 (New Position) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | ANAPTYSBIO INC ANAB | TANG CAPITAL MANAGEMENT, LLC | 1,996,318 4.400% | 1,996,318 (New Position) | Filing History |
| 2024-11-14 09:24 am Sale | 2024-09-30 | 13G | ANAPTYSBIO INC ANAB | Deep Track Capital, LP | 0 0.000% | -3,055,485 (Position Closed) | Filing History |
| 2024-08-16 12:07 pm Purchase | 2024-08-14 | 13D | ANAPTYSBIO INC ANAB | EcoR1 Capital, LLC | 11,692,494 25.800% | 411,858 (+3.65%) | Filing History |
| 2024-07-10 10:10 am Purchase | 2024-07-09 | 13G | ANAPTYSBIO INC ANAB | FMR LLC | 4,305,927 10.507% | 4,039,319 (+1515.08%) | Filing History |
| 2024-05-06 12:59 pm Purchase | 2024-04-29 | 13G | ANAPTYSBIO INC ANAB | Frazier Life Sciences Public Fund L.P. | 2,875,786 7.000% | 2,875,786 (New Position) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | ANAPTYSBIO INC ANAB | TANG CAPITAL PARTNERS LP | 2,925,914 7.300% | -1,017,103 (-25.80%) | Filing History |
| 2024-02-14 10:01 am Sale | 2023-12-31 | 13G | ANAPTYSBIO INC ANAB | Point72 Asset Management, L.P. | 1,182,818 3.000% | -2,003,482 (-62.88%) | Filing History |
| 2024-02-14 08:35 am Purchase | 2023-12-31 | 13G | ANAPTYSBIO INC ANAB | Deep Track Capital, LP | 3,055,485 7.670% | 1,015,221 (+49.76%) | Filing History |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | ANAPTYSBIO INC ANAB | VANGUARD GROUP INC | 2,070,172 5.190% | -595,190 (-22.33%) | Filing History |
| 2024-01-26 5:25 pm Sale | 2023-12-31 | 13G | ANAPTYSBIO INC ANAB | BlackRock Inc. BLK | 2,699,734 6.800% | -84,665 (-3.04%) | Filing History |
| 2023-10-02 4:32 pm Purchase | 2023-09-22 | 13G | ANAPTYSBIO INC ANAB | Deep Track Capital, LP | 2,040,264 5.120% | 2,040,264 (New Position) | Filing History |
| 2023-02-14 4:21 pm Sale | 2022-12-31 | 13G | ANAPTYSBIO INC ANAB | Point72 Asset Management, L.P. | 3,186,300 7.500% | -235,500 (-6.88%) | Filing History |
| 2023-02-10 09:39 am Sale | 2022-12-31 | 13G | ANAPTYSBIO INC ANAB | Deerfield Mgmt, L.P. | 1,742,739 4.090% | -457,161 (-20.78%) | Filing History |
| 2023-02-09 11:07 am Sale | 2022-12-30 | 13G | ANAPTYSBIO INC ANAB | VANGUARD GROUP INC | 2,665,362 6.250% | -98,662 (-3.57%) | Filing History |
| 2023-02-09 10:39 am Sale | 2023-01-31 | 13G | ANAPTYSBIO INC ANAB | FEDERATED HERMES INC. FHI | 2,102,338 4.930% | -1,457,196 (-40.94%) | Filing History |